Z-1396-2024 Class II Ongoing

Recalled by Boston Scientific Corporation — Maple Grove, MN

FDA device recall Z-1396-2024 was initiated by Boston Scientific Corporation on Mar 5, 2024 and is designated Class II. Reason for recall: Certain batches of Opticross 40MHz Coronary Imaging Catheters manufactured using an incorrect voltage setting, which may have resulted in decreased image brightness. The recall status is ongoing. Affected quantity: 239 units.

Recall Details

Product Type
Devices
Report Date
Apr 3, 2024
Initiation Date
Mar 5, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
239 units

Product Description

OptiCross Coronary Imaging Catheter, REF H749518080120

Reason for Recall

Certain batches of Opticross 40MHz Coronary Imaging Catheters manufactured using an incorrect voltage setting, which may have resulted in decreased image brightness.

Distribution Pattern

International distribution to the country of Japan.

Code Information

UDI/DI 08714729938415, Lot Numbers: 32426901, 32429407, 32625286

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1396-2024
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.